References
- Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J. Clin. 60(2), 120–132 (2010).
- Laurent S. Defining vascular aging and cardiovascular risk. J. Hypertens. 30(Suppl.), S3–S8 (2012).
- Wilkerson WR, Sane DC. Aging and thrombosis. Semin. Thromb. Hemost. 28(6), 555–567 (2002).
- Horowitz N, Brenner B. Thrombophilia and cancer. Pathophysiol. Haemost. Thromb. 36(3–4), 131–136 (2008).
- Anderson JA, Weitz JI. Hypercoagulable states. Crit. Care Clin. 27(4), 933–952 (2011).
- Hamilton PJ, Allardyce M, Ogston D, Dawson AA, Douglas AS. The effect of age upon the coagulation system. J. Clin. Pathol. 27(12), 980–982 (1974).
- Ferroni P, Della-Morte D, Palmirotta R et al. Platinum based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention. Rejuvenation Res. 14(3), 293–308 (2011).
- Roselli M, Ferroni P, Riondino S et al. Impact of chemotherapy on activated protein C-dependent thrombin generation – association with VTE occurrence. Int. J. Cancer 133, 1253–1259 (2013).
- Vergati M, Della-Morte D, Ferroni P et al. Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer. Rejuvenation Res. 16(3), 224–231 (2013).
- Leonard RC, Barrett-Lee PJ, Gosney MA, Willett AM, Reed MW, Hammond PJ. Effect of patient age on management decisions in breast cancer: consensus from a national consultation. Oncologist 15(7), 657–664 (2010).
- Kassam F, Shepherd FA, Johnston M et al. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. J. Thorac. Oncol. 2(1), 39–43 (2007).
- Maggiore RJ, Gross CP, Hurria A. Polypharmacy in older adults with cancer. Oncologist 15(5), 507–522 (2010).
- Glotzer OS, Fabian T, Chandra A, Bakhos CT. Non-small cell lung cancer therapy: safety and efficacy in the elderly. Drug. Healthc. Patient Saf. 5, 113–121 (2013).
- Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10), 4902–4907 (2008).
- Steer CB. Chemotherapy for ovarian cancer in the older adult. Curr. Treat. Options Oncol. 10(3–4), 159–170 (2009).
- Ohe Y, Niho S, Kakinuma R et al. A Phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients. Ann. Oncol. 15(1), 45–50 (2004).
- Gridelli C, Maione P, Illiano A et al. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies. J. Clin. Oncol. 25(29), 4663–4669 (2007).
- Puts MTE, Hardt J, Monette J, Girre V, Springall E, Alibhai SMH. Use of geriatric assessment for older adults in the oncology setting: a systematic review. J. Natl. Cancer Inst. 104(15), 1133–1163 (2012).
- Vazzana N, Riondino S, Toto V et al. Obesity driven inflammation and colorectal cancer. Curr. Med. Chem. 19(34), 5837–5853 (2012).
Website
- WHO. 50 Facts: Global health situation and trends 1955–2025. www.who.int/whr/1998/media_centre/50facts/en/ (Accessed 17 June 2013)
- World Population Ageing 2009. www.un.org/esa/population/publications/WPA2009/WPA2009_WorkingPaper.pdf (Accessed 17 June 2013)
- Bloom DE, Boersch-Supan A, McGee P, Seike A. Population Aging: Facts, Challenges, and Responses. PGDA Working Paper No.71 (2011). www.hsph.harvard.edu/pgda/working.htm